CAS No. |
89354-01-8 |
中文名称 |
(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基(3S,3aS,4R,8aR,9R,11aS,13aR,13bR)-4-羟基-3a,13a,13b-三甲基-6-氧代-3,9-二(丙-1-烯-2-基)十八氢环戊并[7,8]菲并[10,1-bc]氧杂䓬-11a(1H)-羧酸酯 |
英文名称 |
(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl (3S,3aS,4R,8aR,9R,11aS,13aR,13bR)-4-hydroxy-3a,13a,13b-trimethyl-6-oxo-3,9-di(prop-1-en-2-yl)octadecahydrocyclopenta[7,8]phenanthro[10,1-bc]oxepine-11a(1H)-carboxylate |
别名 |
Chiisanoside;Androstane-4-propanoic acid, 18-[(O-6-deoxy-α-L-mannopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]-β,6-dihydroxy-4,9-dimethyl-3,15-bis(1-methylethenyl)-18-oxo-, ε-lactone, (βR,3α,4β,5β,6β,8α,9β,10α,13α,14β,15β)- |
标准英文名 |
(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl (3S,3aS,4R,8aR,9R,11aS,13aR,13bR)-4-hydroxy-3a,13a,13b-trimethyl-6-oxo-3,9-di(prop-1-en-2-yl)octadecahydrocyclopenta[7,8]phenanthro[10,1-bc]oxepine-11a(1H)-carboxylate |
分子式 |
C48H74O19 |
分子量 |
955.10
|
精确分子量 |
954.48
|
SMILES |
C=C(C)[C@@H]1CC[C@]2(C(=O)O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)CC[C@]3(C)[C@H](CC4OC(=O)C[C@@H](O)[C@]5(C)C4[C@@]3(C)CC[C@H]5C(=C)C)C12 |
标准SMILES |
C[C@@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CC[C@H](C4[C@H]4CC6OC(=O)C[C@@H](O)[C@]7(C)C6[C@@](C)(CC[C@H]7C(C)=C)[C@]4(C)CC5)C(C)=C)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O |
用途 |
Neuroprotective; anticancer; antidepressant; anti-inflammatory; anti-obesity; antiplatelet activity; inhibits tumor growth via immunomodulation, induction of apoptosis, and inhibition of angiogenesis; ameliorates Parkinson’s disease by modulating the Parkin/ZNF746/PGC-1α axis and promoting mitochondrial biogenesis. |
InChIKey |
JVLBOZIUMGNKQW-WTPFMMGYSA-N |